A Word from Establishment Labs on the FDA's Announcement About ALCL

A Word from Establishment Labs on the FDA's Announcement About ALCL

To date, there have been no reported cases of BIA-ALCL in women with Motiva Implants®.

Establishment Labs has spent the last decade developing and improving novel manufacturing processes that supersede traditional salt-loss macro-textures. We are committed to the safety of our products and the health of women who choose them by offering advanced technologies like our proprietary SilkSurface®.

Read More